Skip to content
Disclosery

EXANE DERIVATIVES: KLAC position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on KLAC, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 486 KLAC shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 486 shares
    Change vs previous 13F -1,244 shares

    0.09% of the 13F portfolio, value $155,057.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 1,730 shares
    Change vs previous 13F +190 shares

    0.18% of the 13F portfolio, value $633,265.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 1,540 shares
    Change vs previous 13F +355 shares

    0.16% of the 13F portfolio, value $662,366.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 1,185 shares
    Change vs previous 13F -16 shares

    0.1% of the 13F portfolio, value $396,393.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,201 shares
    Change vs previous 13F -648 shares

    0.09% of the 13F portfolio, value $374,242.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,849 shares
    Change vs previous 13F -39 shares

    0.18% of the 13F portfolio, value $610,906.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 1,888 shares
    Change vs previous 13F -258 shares

    0.15% of the 13F portfolio, value $488,818.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 2,146 shares
    Change vs previous 13F not available

    0.14% of the 13F portfolio, value $415,756.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).